Biogen Halts Studies of Closely Watched Alzheimer's Drug, a Blow to Hopes for New Treatment
Published Date: 3/22/2019
Source: scientificamerican.com
Trial failure raises doubts about amyloid as a target for drug development -- Read more on ScientificAmerican.com